EMAIL DETAILS

RSTP Team,

Below is Counsyl's official press release. We feature prominently which is
great. Awesome job everyone bringing this over the finish line. Now is the
time to work together to help the company scale faster and we can discuss
this on our Partner call on Monday.

With this closing it brings RSTP's assets under management to about $60
million, with about $51 million being fully invested in Counsyl. It also
brings our assets under management from Goldman Sachs to $48 million.

We are going to use our ability to syndicate another $20 million of the
Series D to bring new investors into our blind pool fund with direct
co-investment rights for the Counsyl deal. This deal should be a great
catalyst to move folks off the fence.

Wires for fees relating to RSTP II, L.P. and RSTP II Bravo LLC will go out
tomorrow.

Congrats to all!

Best,

John


*Counsyl Unveils First Highly Scalable, Automated Health Information
Platform and Gives People Low Cost Access to Vital Information about Their
Bodies*

*Counsyl Launches Inherited Cancer Screen and Advances Family Prep Screen
Using Latest in Sequencing Technology To Deliver Results in Two Weeks or
Less; Raises $28M To Further Product Expansion, Bringing Total Financing to
$93M*

*Counsyl Announces 250,000 Patients Screened and 14,000 Medical
Professionals Served -- Changing The Way People Make Choices About Their
Lives*
May 08, 2014 09:00 AM Eastern Daylight Time

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE <http://www.businesswire.com/>
)--Counsyl<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=Counsyl&index=1&md5=616b98ea2f05b83fa61c75f46fe6518e>,
a technology company that gives people access to vital information about
their bodies, unveils the first scalable, comprehensive platform for people
to request and receive important health information in two weeks or less.
Counsyl launches the Inherited Cancer Screen starting with cancer
susceptibility genes *BRCA1* and *BRCA2* and advances its Family Prep
Screen using the latest in sequencing technology for couples planning to
start a family.

“In my opinion, Counsyl Complete holds the promise to revolutionize the way
doctors and laboratories interact. This product is an innovation that is
overdue and a welcome partnership that we hope will prove to be an asset to
our practice and our patients”

Counsyl also announces it has raised $28 million in Series D financing
co-led by Rosemont Seneca Technology Partners and Goldman Sachs Asset
Management bringing total financing to $93 million. The company will use
the funds to continue to invest in product development. By reducing the
cost of previously expensive laboratory procedures, Counsyl is giving
people and physicians access to medical data that is truly actionable.
Today this includes an Inherited Cancer Screen and Family Prep Screen, with
a future roadmap for delivering comprehensive screening for a wide range of
vital health information.

“We want to make it easy and affordable for people to get screened for a
wide range of meaningful information that can have a real influence on
their health,” said Ramji Srinivasan, co-founder and Chief Executive
Officer of Counsyl. “We have made a conscious decision to screen for
diseases that give more people more choices in their lives.”

*New Inherited Cancer Screen*

Research shows that five to 10 percent of cancers are inherited. Counsyl’s
new *BRCA1 *and* BRCA2* screen informs men and women if they have inherited
a high risk for breast, ovarian, prostate, and pancreatic cancers. Counsyl
provides advanced knowledge that gives people options to prepare, plan and
do things to improve their health. For example, learning this vital
information can help doctors identify patients who are at high risk for
certain cancers. Doctors then can recommend more frequent, advanced
screening than the average guidelines suggest. Counsyl’s offerings will
soon include screens for other inherited cancers.

Holly T., a hairstylist and mother from Camarillo, Calif., recently took
the Counsyl Inherited Cancer Screen as cancer runs in her family. Holly
said, “Knowing this information allows me to be proactive. I want to be
here for my kids, and I want to do everything I can to stay healthy.”

*Advances to Family Prep Screen*

Using sophisticated new sequencing technology, the Counsyl Family Prep
Screen gives couples who are planning to have a baby information about
hundreds of diseases they may unknowingly pass to future generations. A
positive result means that a prospective parent is a healthy “carrier” of a
genetic disease. When both parents are carriers of the same disease, they
have a one in four chance of giving birth to a child that is at risk for
that disease. These are health conditions where advanced knowledge can
change the way a couple approaches family planning.

“You can take control of what you’ve been given and do something with it
for the positive,” notes Jennifer B., a nurse and mother who learned that
she and her husband were carriers of a severe disease, Smith-Lemli-Opitz
Syndrome, and chose specialized fertility treatments to have a healthy baby.

*Launching Counsyl Complete Platform*

In addition, the company is announcing Counsyl Complete, a platform for
online communication of results between physicians and patients. Physicians
who offer the Counsyl Complete service have access to a complete set of
online tools to allow them to easily track, monitor and follow up with
patients.

Through a private online account, physicians can give results directly to
patients along with educational videos that explain the significance of the
findings. Patients who have additional questions can schedule complimentary
telephone counseling with an experienced medical professional from Counsyl
during daytime, evening and weekend hours. Compared to the standard wait
time of several weeks or months, physicians can now connect patients to a
genetic counselor online and expect to receive written documentation
following the call.

“In my opinion, Counsyl Complete holds the promise to revolutionize the way
doctors and laboratories interact. This product is an innovation that is
overdue and a welcome partnership that we hope will prove to be an asset to
our practice and our patients," said Mitchell Nudelman MD, Bellegrove
Ob/Gyn.

*Highly Automated Counsyl Lab*

Counsyl integrates sophisticated technology with custom automation in its
CLIA-certified, CAP-accredited and NYS CLEP-permitted medical laboratory.
Designed from the ground up by a world-class team of scientists and
engineers, Counsyl’s lab has created unparalleled efficiencies in the
medical testing industry.

“We are able to introduce new technology that allows us to process 10 times
more samples per person than traditional molecular labs,” said Dr. Eric
Evans, co-founder and Chief Science Officer at Counsyl. “Building an
efficient, scalable lab that uses sophisticated machinery and algorithms to
produce reliable data is a never-ending process. We’re constantly adding
new hardware and evaluating new technologies to ensure that millions of
people have access to critical information.”

Counsyl uses custom-built robots to process blood and saliva samples
working alongside Counsyl’s team of scientists and engineers to
simultaneously analyze thousands of DNA samples with precision, accuracy
and unparalleled efficiency.

When a sample reaches the laboratory, Counsyl’s robots use a unique barcode
to identify and track the sample from start to finish. Robotic extraction
and preparation of purified DNA ensures precision, which is a vital aspect
of Counsyl’s ability to analyze thousands of samples each day. These robots
are engineered from machines that are used for similarly precise
procedures, like laser eye surgery.

“Our team of engineers can take raw medical data and turn it into a clear
online report,” said Rishi Kacker, Counsyl co-founder and VP of
engineering. “We’ve had to build our software systems from the ground up to
offer a simple and intuitive experience while managing complex order flows,
billing, fulfillment, and on-call counseling behind the scenes.”

*Counsyl Medical Professionals*

Members of the Counsyl clinical team are certified by the American Board of
Genetic Counseling and were recruited from top academic centers, including
Johns Hopkins Hospital, Weill Cornell Medical Center and UCSF Medical
Center. They are passionate about translating scientific data into
actionable information to help people make educated choices that are
consistent with their personal beliefs.

*How To Get Counsyl*

Step 1: Request
Request Counsyl online at
www.counsyl.com<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=www.counsyl.com&index=2&md5=8c809446d814146cb5a69553d92a34c8>.
Counsyl will contact your physician to obtain medical approval. If you are
planning to use insurance, you can use the Counsyl price
estimator<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=price+estimator&index=3&md5=4ff812d632e6c627b484fe2c46de8960>
to
help calculate the cost.

Step 2: Register
Receive a registered kit in the mail, along with instructions for sample
collection.

Step 3: Submit
Submit a saliva specimen in the plastic tube provided within each kit and
send the sample back to Counsyl in a prepaid envelope.

Step 4: Learn
Get your results within two weeks, with an option to review your findings
with a medical professional at Counsyl.

*Pricing for Counsyl*

Counsyl offers people an online price
estimator<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.counsyl.com%2Fprice&esheet=50860364&newsitemid=20140508005895&lan=en-US&anchor=online+price+estimator&index=4&md5=306d058acdcff869f485945d9cf44b21>
that
allows them to input their insurance information and receive a quote within
seconds. This upfront pricing transparency allows people to know what the
price will be before a test has been performed. Eligible patients typically
pay between $150-300 depending on the test and their insurance coverage.

*About Counsyl*

Counsyl is a technology company that strives to give millions of men and
women access to vital information about their bodies so they can
confidently make choices about their lives. Counsyl integrates
sophisticated technology with custom automation in its CLIA-certified,
CAP-accredited and NYS CLEP-permitted medical laboratory. The Counsyl
Family Prep Screen has already helped hundreds of thousands of people
discover critical information before having children, and the Counsyl
platform now includes inherited cancer screening. Counsyl has raised a
total of $93 million and is privately backed by Rosemont Seneca Technology
Partners, Goldman Sachs Asset Management, Founders Fund, Felicis Ventures,
David Drummond, and other high profile investors.
John DeLoche
*Co-founder and Managing Director*
Rosemont Seneca Technology Partners
333 Bush Street, 21st Floor
San Francisco, CA 94104
office: 415 767 1288
mobile: 415 793 7070

This email communication is privileged and confidential and is intended
only for the individuals or entities named above. Any unauthorized
dissemination of any of the contents of this email is strictly prohibited.
If you are not the intended recipient, please do not read, copy, use or
disclose to others the contents of this communication. Please notify the
sender that you have received this e-mail in error and then delete the
e-mail